Paul Tudor Jones Cure Vac N.V. Call Options Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CVAC
# of Institutions
95Shares Held
15.3MCall Options Held
31.4KPut Options Held
137K-
Israel Englander Millennium Management LLC | New York, Ny2.76MShares$9.39 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.97MShares$6.71 Million0.0% of portfolio
-
Camber Capital Management LP Boston, MA1.75MShares$5.95 Million0.13% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.6MShares$5.43 Million5.88% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il981KShares$3.33 Million0.0% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $637M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...